168 related articles for article (PubMed ID: 23861745)
1. Characterization of DNA binding property of the HIV-1 host factor and tumor suppressor protein Integrase Interactor 1 (INI1/hSNF5).
Das S; Banerjee B; Hossain M; Thangamuniyandi M; Dasgupta S; Chongdar N; Kumar GS; Basu G
PLoS One; 2013; 8(7):e66581. PubMed ID: 23861745
[TBL] [Abstract][Full Text] [Related]
2. Integrase interactor 1 in health and disease.
Das S
Curr Protein Pept Sci; 2015; 16(6):478-90. PubMed ID: 25772157
[TBL] [Abstract][Full Text] [Related]
3. Comparative molecular genetic analysis of simian and human HIV-1 integrase interactor INI1/SMARCB1/SNF5.
Pyeon D; Price L; Park IW
Arch Virol; 2015 Dec; 160(12):3085-91. PubMed ID: 26350979
[TBL] [Abstract][Full Text] [Related]
4. Multimerization and DNA binding properties of INI1/hSNF5 and its functional significance.
Das S; Cano J; Kalpana GV
J Biol Chem; 2009 Jul; 284(30):19903-14. PubMed ID: 19398554
[TBL] [Abstract][Full Text] [Related]
5. Integrase interactor 1 (Ini1/hSNF5) is a repressor of basal human immunodeficiency virus type 1 promoter activity.
Boese A; Sommer P; Holzer D; Maier R; Nehrbass U
J Gen Virol; 2009 Oct; 90(Pt 10):2503-2512. PubMed ID: 19515827
[TBL] [Abstract][Full Text] [Related]
6. Structure-function analysis of integrase interactor 1/hSNF5L1 reveals differential properties of two repeat motifs present in the highly conserved region.
Morozov A; Yung E; Kalpana GV
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1120-5. PubMed ID: 9448295
[TBL] [Abstract][Full Text] [Related]
7. Specificity of interaction of INI1/hSNF5 with retroviral integrases and its functional significance.
Yung E; Sorin M; Wang EJ; Perumal S; Ott D; Kalpana GV
J Virol; 2004 Mar; 78(5):2222-31. PubMed ID: 14963118
[TBL] [Abstract][Full Text] [Related]
8. Complementation analyses suggest species-specific functions of the SNF5 homology domain.
Bonazzi V; Medjkane S; Quignon F; Delattre O
Biochem Biophys Res Commun; 2005 Oct; 336(2):634-8. PubMed ID: 16154112
[TBL] [Abstract][Full Text] [Related]
9. INI1/hSNF5-interaction defective HIV-1 IN mutants exhibit impaired particle morphology, reverse transcription and integration in vivo.
Mathew S; Nguyen M; Wu X; Pal A; Shah VB; Prasad VR; Aiken C; Kalpana GV
Retrovirology; 2013 Jun; 10():66. PubMed ID: 23799881
[TBL] [Abstract][Full Text] [Related]
10. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.
Lee S; Cimica V; Ramachandra N; Zagzag D; Kalpana GV
Cancer Res; 2011 May; 71(9):3225-35. PubMed ID: 21521802
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of early stages of HIV-1 assembly by INI1/hSNF5 transdominant negative mutant S6.
Cano J; Kalpana GV
J Virol; 2011 Mar; 85(5):2254-65. PubMed ID: 21159874
[TBL] [Abstract][Full Text] [Related]
12. The human SNF5/INI1 protein facilitates the function of the growth arrest and DNA damage-inducible protein (GADD34) and modulates GADD34-bound protein phosphatase-1 activity.
Wu DY; Tkachuck DC; Roberson RS; Schubach WH
J Biol Chem; 2002 Aug; 277(31):27706-15. PubMed ID: 12016208
[TBL] [Abstract][Full Text] [Related]
13. The integrase interactor 1 (INI1) proteins facilitate Tat-mediated human immunodeficiency virus type 1 transcription.
Ariumi Y; Serhan F; Turelli P; Telenti A; Trono D
Retrovirology; 2006 Aug; 3():47. PubMed ID: 16889668
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1.
Wu DY; Kalpana GV; Goff SP; Schubach WH
J Virol; 1996 Sep; 70(9):6020-8. PubMed ID: 8709224
[TBL] [Abstract][Full Text] [Related]
15. The C-terminal SET domains of ALL-1 and TRITHORAX interact with the INI1 and SNR1 proteins, components of the SWI/SNF complex.
Rozenblatt-Rosen O; Rozovskaia T; Burakov D; Sedkov Y; Tillib S; Blechman J; Nakamura T; Croce CM; Mazo A; Canaani E
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4152-7. PubMed ID: 9539705
[TBL] [Abstract][Full Text] [Related]
16. The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors.
Caramel J; Medjkane S; Quignon F; Delattre O
Oncogene; 2008 Mar; 27(14):2035-44. PubMed ID: 17922027
[TBL] [Abstract][Full Text] [Related]
17. The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization.
Medjkane S; Novikov E; Versteege I; Delattre O
Cancer Res; 2004 May; 64(10):3406-13. PubMed ID: 15150092
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional role of INI1 and LEDGF in the HIV-1 preintegration complex.
Maillot B; Lévy N; Eiler S; Crucifix C; Granger F; Richert L; Didier P; Godet J; Pradeau-Aubreton K; Emiliani S; Nazabal A; Lesbats P; Parissi V; Mely Y; Moras D; Schultz P; Ruff M
PLoS One; 2013; 8(4):e60734. PubMed ID: 23593299
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the SNF5 transcription factor gene abolishes the lethal phenotype induced by the expression of HIV-1 integrase in yeast.
Parissi V; Caumont A; Richard de Soultrait V; Dupont CH; Pichuantes S; Litvak S
Gene; 2000 Apr; 247(1-2):129-36. PubMed ID: 10773452
[TBL] [Abstract][Full Text] [Related]
20. A masked NES in INI1/hSNF5 mediates hCRM1-dependent nuclear export: implications for tumorigenesis.
Craig E; Zhang ZK; Davies KP; Kalpana GV
EMBO J; 2002 Jan; 21(1-2):31-42. PubMed ID: 11782423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
